<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1024</article-id><article-id pub-id-type="doi">10.15690/vramn1024</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ENDOCRINOLOGY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ ЭНДОКРИНОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">SNP Association with Risk for Sporadic Papillary Thyroid Carcinoma in Kazakh Population</article-title><trans-title-group xml:lang="ru"><trans-title>Однонуклеотидные полиморфизмы, ассоциированные со спорадическим папиллярным раком щитовидной железы, в казахской популяции</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7701-9832</contrib-id><name-alternatives><name xml:lang="en"><surname>Krykpayeva</surname><given-names>Ainur S.</given-names></name><name xml:lang="ru"><surname>Крыкпаева</surname><given-names>Айнур Сериковна</given-names></name></name-alternatives><address><country country="KZ">Kazakhstan</country></address><bio xml:lang="en"><p>PhD-student</p></bio><bio xml:lang="ru"><p>Докторант PhD, ассистент</p></bio><email>k.ainur.85@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9036-8735</contrib-id><name-alternatives><name xml:lang="en"><surname>Nakashima</surname><given-names>Masahiro</given-names></name><name xml:lang="ru"><surname>Накашима</surname><given-names>Масахиро</given-names></name></name-alternatives><address><country country="JP">Japan</country></address><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><bio xml:lang="ru"><p>Доктор медицинских наук, профессор</p></bio><email>moemoe@nagasaki-u.ac.jp</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2318-4765</contrib-id><name-alternatives><name xml:lang="en"><surname>Espenbetova</surname><given-names>Maira Zh.</given-names></name><name xml:lang="ru"><surname>Еспенбетова</surname><given-names>Майра Жаксимановна</given-names></name></name-alternatives><address><country country="KZ">Kazakhstan</country></address><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><bio xml:lang="ru"><p>Доктор медицинских наук, профессор</p></bio><email>espenbetova@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7315-7725</contrib-id><name-alternatives><name xml:lang="en"><surname>Mussazhanova</surname><given-names>Zhanna</given-names></name><name xml:lang="ru"><surname>Мусажанова</surname><given-names>Жанна Бахытгереевна</given-names></name></name-alternatives><address><country country="JP">Japan</country></address><bio xml:lang="en"><p>MD, PhD, AssistantProfessor.</p><p>852-8523, Sakamoto 1-12-4, Nagasaky</p></bio><bio xml:lang="ru"><p>Ассистент профессора.</p><p>852-8523, Сакамото 1-12-4, Нагасаки, тел.: +(81) 958-197-107</p></bio><email>ghannakz@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4775-8970</contrib-id><name-alternatives><name xml:lang="en"><surname>Azizov</surname><given-names>Baurzhan S.</given-names></name><name xml:lang="ru"><surname>Азизов</surname><given-names>Бауыржан Слямович</given-names></name></name-alternatives><address><country country="KZ">Kazakhstan</country></address><bio xml:lang="en"><p>MD</p></bio><email>aiaziz@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Semey State Medical University</institution></aff><aff><institution xml:lang="ru">Государственный медицинский университет города Семей</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Nagasaki University</institution></aff><aff><institution xml:lang="ru">Университет Нагасаки, Институт болезней атомной бомбы</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-28" publication-format="electronic"><day>28</day><month>12</month><year>2018</year></pub-date><volume>73</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>431</fpage><lpage>435</lpage><history><date date-type="received" iso-8601-date="2018-08-15"><day>15</day><month>08</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-12-01"><day>01</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Издательство "Педиатръ"</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2019-12-28"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnikramn.spr-journal.ru/jour/about/submissions</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/1024">https://vestnikramn.spr-journal.ru/jour/article/view/1024</self-uri><abstract xml:lang="en"><p><bold>Background:</bold> The recent genome-wide association studies (GWAS) including FOXE1 and NKX2-1 genes have represent associations for well differentiated thyroid carcinoma. Replication studies in geographically distinct populations identified strong associations of rs965513 (9q22.33) and rs944289 (14q13.3) SNPs with papillary thyroid cancer. This work is the first to characterise the associations of SNPs in a population-based Kazakh cohort.</p><p><bold>Aims:</bold> To study association of SNPs with risk for sporadic papillary thyroid carcinoma (PTC) in Kazakh population.</p><p><bold>Materials and methods</bold>: A total of 298 patients with histologically confirmed PTC and 742 controls of Kazakh origin were recruited. All participants donated a peripheral venous blood sample which was used to isolate genomic DNA. Genotyping was performed using TaqMan Genotyping on a Light Cycler 480 (Roche, Indianapolis, IN).</p><p><bold>Results:</bold> Significant associations: rs965513 (p=3.24 E-16; OR=2.05, 95% CI 1.82−2.11) and rs944289 (p=1.38 E-06; OR=1.39, 95% CI 1.21−1.52) were found in the multiplicative model of inheritance adjusted for age and sex.</p><p><bold>Conclusions:</bold> Our study unambiguously confirms the existence of genetic determinants of susceptibility to PTC in Kazakh population.</p></abstract><trans-abstract xml:lang="ru"><p/><p><bold>Обоснование.</bold> В последние несколько лет были проведены полногеномные поиски ассоциаций (Genome-Wide Association Studies) экспрессии генов FOXE1 и NKX2-1, определяемые генным однонуклеотидным полиморфизмом (Single Nucleotide Polymorphism, SNP), c морфологически верифицированным раком щитовидной железы. Последующие исследования репликаций в разных популяциях выявили сильные ассоциации SNP rs965513 и rs944289, локализующихся в генах FOXE1 и NKX2-1 соответственно, с папиллярным раком щитовидной железы. Настоящая работа является первым ассоциативным исследованием данных SNP со спорадическим папиллярным раком щитовидной железы в казахской популяции.</p><p><bold>Цель исследования</bold> ― изучить ассоциацию SNP rs965513 и rs944289 с папиллярным раком щитовидной железы в казахской популяции.</p><p><bold>Методы.</bold> Нами было проведено исследование методом случай-контроль, в котором приняли участие 298 пациентов, имеющих в анамнезе папиллярный рак щитовидной железы; в качестве популяционного контроля привлечены 742 человека, не имевших заболеваний щитовидной железы. Всего было обследовано 1040 лиц казахской популяции. Однонуклеотидные полиморфизмы rs965513 и rs944289 определяли методом зондов с гидролизующейся пробой, используя для генотипирования ДНК клеток периферической крови.</p><p><bold>Результаты</bold>. Значительные ассоциации rs965513 (p=3,24 E-16; OR=2,05, 95% CI 1,82−2,11) и rs944289 (p=1,38 E-06; OR=1,39, 95% CI 1,21−1,52) были выявлены многофакторным логистическим регрессионным анализом в мультипликативной модели наследования.</p><p><bold>Заключение.</bold> В результате нашего исследования выявлена взаимосвязь двух исследованных однонуклеотидных полиморфизмов ― rs965513 и rs944289 ― с предрасположенностью к папиллярному раку щитовидной железы в казахской популяции.</p><bold/></trans-abstract><kwd-group xml:lang="en"><kwd>thyroid cancer</kwd><kwd>papillary thyroid cancer</kwd><kwd>single nucleotide polymorphism</kwd><kwd>kazakh population</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак щитовидной железы</kwd><kwd>папиллярный рак щитовидной железы</kwd><kwd>однонуклеотидный полиморфизм</kwd><kwd>казахская популяция</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Kweon SS, Shin MH, Chung IJ, et al. Thyroid cancer is the most common cancer in women, based on the data from population-based cancer registries, South Korea. Jpn J Clin Oncol. 2013;43(10):1039–1046. doi: 10.1093/jjco/hyt102.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kimura ET, Nikiforova MN, Zhu Z, et al. High prevalence of BRAF mutations in thyroid cancer. Cancer Res. 2003;63(7):1454–1457.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Lloyd RV, Osamura RY, Klöppel G, Rosai J, editors. WHO Classification of Tumours of endocrine organs. WHO Classification of Tumours, 4th ed. Vol. 10. WHO; 2017. 355 p.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Cardis E, Kesminiene A, Ivanov V, et al. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst. 2005;97(10):724–732. doi: 10.1093/jnci/dji129.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Takahashi M, Saenko VA, Rogounovitch TI, et al. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet. 2010;19(12):2516–2523. doi: 10.1093/hmg/ddq123.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet. 2009;41(4):460–464. doi: 10.1038/ng.339.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Matsuse M, Takahashi M, Mitsutake N, et al. The FOXE1 and NKX2–1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet. 2011;48(9):645–648. doi: 10.1136/jmedgenet-2011-100063.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Pereda C, Lesueur F, Pertesi M, et al. Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population. BMC Genet. 2015;16:22. doi: 10.1186/s12863-015-0180-5.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Penna-Martinez M, Epp F, Kahles H, et al. FOXE1 association with differentiated thyroid cancer and its progression. Thyroid. 2014;24(5):845–851. doi: 10.1089/thy.2013.0274.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Jones AM, Howarth KM, Martin L, et al. Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J Med Genet. 2012;49(3):158–163. doi: 10.1136/jmedgenet-2011-100586.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Guazzi S, Price M, De Felice M, et al. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J. 1990;9(11):3631–3639. doi: 10.1002/j.1460-2075.1990.tb07574.x.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Kendall J, Liu Q, Bakleh A, et al. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci U S A. 2007;104(42):16663–16668. doi: 10.1073/pnas.0708286104.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Kimura S, Hara Y, Pineau T, et al. The T/ebp null mouse: thyroid-speciﬁc enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev. 1996;10(1):60–69. doi: 10.1101/gad.10.1.60.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Li W, Ain KB. Human sodium–iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells. Endocr Relat Cancer. 2010;17(2):383–398. doi: 10.1677/ERC-09-0156.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Mitchell LE, Christensen K. Evaluation of family history data for Danish twins with nonsyndromic cleft lip with or without cleft palate. Am J Med Genet. 1997;72(1):120–121. doi: 10.1002/(sici)1096-8628(19971003)72:1&lt;120::aid-ajmg25&gt;3.0.co;2-s.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Tomaz RA, Sousa I, Silva JG, et al. FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility. Clin Endocrinol (Oxf). 2012;77(6):926–933. doi: 10.1111/j.1365-2265.2012.04505.x.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Abramson JH. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov. 2011;8(1):1. doi: 10.1186/1742-5573-8-1.</mixed-citation></ref></ref-list></back></article>
